31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1153 21 1096 96 1169 175 1065
ERLYTX 85 2 104 8 97 16 97
GI 169 1 52 9 110 26 158
GU 346 7 365 38 463 76 463
LEUK 163 3 157 15 183 37 225
LUNG 208 4 209 20 244 40 244
LYMPH 424 10 522 37 450 76 463
MELAN 38 0 0 0 0 0 0
MMYEL 119 3 157 11 134 20 122
MULT 50 0 0 5 61 10 61
OTHER 55 0 0 3 37 7 43
Total 2810 51 2662 242 2948 483 2941

31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 185 3 157 24 292 42 256
ERLYTX 5 0 0 0 0 1 6
GU 5 0 0 1 12 1 6
LEUK 621 9 470 49 597 102 621
LUNG 377 4 209 34 414 53 323
MELAN 3 0 0 3 37 3 18
OTHER 11 0 0 0 0 1 6
PEOLC 93 0 0 4 49 7 43
PREV 248 3 157 12 146 42 256
SXQOL 658 11 574 68 828 110 670
Total 2207 31 1619 196 2387 363 2211

31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 1153 21 1096 96 1169 175 1065
CCD 185 3 157 24 292 42 256
ERLYTX 90 2 104 8 97 17 103
GI 169 1 52 9 110 26 158
GU 351 7 365 39 475 77 469
LEUK 784 12 626 64 779 139 846
LUNG 585 8 417 54 657 93 566
LYMPH 424 10 522 37 450 76 463
MELAN 41 0 0 3 37 3 18
MMYEL 119 3 157 11 134 20 122
MULT 50 0 0 5 61 10 61
OTHER 66 0 0 3 37 8 49
PEOLC 93 0 0 4 49 7 43
PREV 248 3 157 12 146 42 256
SXQOL 658 11 574 68 828 110 670
Total 5017 82 4279 438 5333 846 5151

31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 716 12 626 61 743 100 609
ERLYTX 58 2 104 7 85 13 79
GI 127 1 52 8 97 21 128
GU 265 6 313 27 329 56 341
LEUK 101 2 104 10 122 24 146
LUNG 126 2 104 11 134 21 128
LYMPH 277 6 313 23 280 49 298
MELAN 25 0 0 0 0 0 0
MMYEL 68 1 52 8 97 12 73
MULT 20 0 0 3 37 5 30
OTHER 55 0 0 3 37 7 43
Total 1838 32 1668 161 1961 308 1875

31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 139 1 52 16 195 27 164
ERLYTX 5 0 0 0 0 1 6
GU 5 0 0 1 12 1 6
LEUK 264 4 209 19 231 42 256
LUNG 229 3 157 22 268 34 207
MELAN 3 0 0 3 37 3 18
OTHER 11 0 0 0 0 1 6
PEOLC 72 0 0 4 49 7 43
PREV 248 3 157 12 146 42 256
SXQOL 485 10 522 51 621 79 481
Total 1461 21 1097 128 1559 237 1443

31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 895 15 783 80 974 134 816
CCD 161 1 52 9 110 21 128
ERLYTX 63 2 104 7 85 14 85
GI 133 2 104 7 85 23 140
GU 302 6 313 32 390 61 371
LEUK 366 6 313 29 353 66 402
LUNG 379 5 261 36 438 61 371
LYMPH 277 6 313 23 280 49 298
MELAN 28 0 0 3 37 3 18
MMYEL 68 1 52 8 97 12 73
MULT 41 3 157 4 49 6 37
OTHER 158 0 0 4 49 9 55
PEOLC 71 0 0 4 49 6 37
PREV 248 3 157 12 146 42 256
SXQOL 485 10 522 51 621 79 481
Total 3675 60 3131 309 3763 586 3568

31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 979 20 1044 89 1084 162 986
ERLYTX 80 2 104 8 97 16 97
GI 100 1 52 3 37 14 85
GU 246 6 313 28 341 55 335
LEUK 133 3 157 14 170 33 201
LUNG 183 4 209 18 219 37 225
LYMPH 354 7 365 29 353 61 371
MMYEL 103 2 104 8 97 17 103
MULT 50 0 0 5 61 10 61
Total 2228 45 2348 202 2459 405 2464

31-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1925 29 1513 155 1887 313 1905
AFFIL 142 2 104 8 97 20 122
CCOP/NCORP 1232 22 1148 126 1534 212 1291
Non-SWOG 1716 27 1409 147 1790 299 1820
Total 5015 80 4174 436 5308 844 5138

31-JUL-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK MM1OA-S04 MyeloMATCH: AML, ASTX727 + Ven (28D v 14D) 1 Y 22-JUL-26
ERLYTX S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT 1 Y 06-JUL-26

31-JUL-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 1 E 30-JUN-26
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 2 E 30-JUN-26
GI S1922 Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect 1 N 15-JUL-26
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 T 09-JUL-26

31-JUL-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 17
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 9
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 6
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
LUNG LUNGMAP NSCLC, Adv, Master 2 4
LUNG LUNGMAP NSCLC, Adv, Master 1 4
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 4
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 4
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 3
MULT S2101 Melan or HNSCC, Adv, Cabo + Nivo 1 3
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3